These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
13. [Treatment of cholestatic liver diseases with ursodeoxycholic acid]. Boberg KM; Schrumpf E Tidsskr Nor Laegeforen; 1997 Sep; 117(23):3370-3. PubMed ID: 9411890 [TBL] [Abstract][Full Text] [Related]
14. Ursodeoxycholic acid in the treatment of primary sclerosing cholangitis. Stiehl A Ann Med; 1994 Oct; 26(5):345-9. PubMed ID: 7826595 [TBL] [Abstract][Full Text] [Related]
15. Medical treatment of primary biliary cirrhosis and primary sclerosing cholangitis. Rust C; Beuers U Clin Rev Allergy Immunol; 2005 Apr; 28(2):135-45. PubMed ID: 15879619 [TBL] [Abstract][Full Text] [Related]
16. Characteristics and clinical course of primary sclerosing cholangitis in France: a prospective cohort study. Garioud A; Seksik P; Chrétien Y; Corphechot C; Poupon R; Poupon RE; Chazouillères O Eur J Gastroenterol Hepatol; 2010 Jul; 22(7):842-7. PubMed ID: 19779305 [TBL] [Abstract][Full Text] [Related]
17. Effect of high-dose ursodeoxycholic acid on its biliary enrichment in primary sclerosing cholangitis. Rost D; Rudolph G; Kloeters-Plachky P; Stiehl A Hepatology; 2004 Sep; 40(3):693-8. PubMed ID: 15349909 [TBL] [Abstract][Full Text] [Related]
18. High dose ursodeoxycholic acid for the treatment of primary sclerosing cholangitis is safe and effective. Cullen SN; Rust C; Fleming K; Edwards C; Beuers U; Chapman RW J Hepatol; 2008 May; 48(5):792-800. PubMed ID: 18314215 [TBL] [Abstract][Full Text] [Related]
19. Ursodeoxycholic acid therapy for primary sclerosing cholangitis: results of a 2-year randomized controlled trial to evaluate single versus multiple daily doses. van Hoogstraten HJ; Wolfhagen FH; van de Meeberg PC; Kuiper H; Nix GA; Becx MC; Hoek AC; van Houte DP; Rijk MC; Salemans JM; Scherpenisse J; Schrijver M; Smit AM; Spoelstra P; Stadhouders PH; Tan TG; Hop WC; ten Kate FJ; vanBerge-Henegouwen GP; Schalm SW; van Buuren HR J Hepatol; 1998 Sep; 29(3):417-23. PubMed ID: 9764988 [TBL] [Abstract][Full Text] [Related]
20. Does ursodeoxycholic acid mediate immunomodulatory and anti-inflammatory effects in patients with primary sclerosing cholangitis? van Milligen de Wit AW; Kuiper H; Camoglio L; van Bracht J; Jones EA; Tytgat GN; van Deventer SJ Eur J Gastroenterol Hepatol; 1999 Feb; 11(2):129-36. PubMed ID: 10102223 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]